Does IRBESARTAN Cause Decreased appetite? 121 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 121 reports of Decreased appetite have been filed in association with IRBESARTAN (Irbesartan). This represents 1.2% of all adverse event reports for IRBESARTAN.
121
Reports of Decreased appetite with IRBESARTAN
1.2%
of all IRBESARTAN reports
6
Deaths
63
Hospitalizations
How Dangerous Is Decreased appetite From IRBESARTAN?
Of the 121 reports, 6 (5.0%) resulted in death, 63 (52.1%) required hospitalization, and 12 (9.9%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 121 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which IRBESARTAN Alternatives Have Lower Decreased appetite Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE